世界の強皮症治療市場規模・現状・予測2021-2027

【英語タイトル】Global Scleroderma Therapy Solutions Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21JNE2850)・商品コード:QY21JNE2850
・発行会社(調査会社):QYResearch
・発行日:2021年6月
・ページ数:107
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥510,900見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥766,350見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、強皮症治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(免疫療法、抗線維化薬、その他)、用途別市場規模(病院、クリニック、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・強皮症治療の市場動向
・企業の競争状況、市場シェア
・強皮症治療の種類別市場規模(免疫療法、抗線維化薬、その他)
・強皮症治療の用途別市場規模(病院、クリニック、その他)
・強皮症治療の北米市場規模2016-2027(アメリカ、カナダ)
・強皮症治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・強皮症治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・強皮症治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・強皮症治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Bayer、Merck、AbbVie、Bristol-Myers Squibb、Sanofi、Roche、GlaxoSmithKline、Pfizer、Boehringer Ingelheim、Novartis)
・結論
【レポートの概要】

Market Analysis and Insights: Global Scleroderma Therapy Solutions Market
The global Scleroderma Therapy Solutions market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Scleroderma Therapy Solutions market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Scleroderma Therapy Solutions market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Scleroderma Therapy Solutions market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Scleroderma Therapy Solutions market.

Global Scleroderma Therapy Solutions Scope and Market Size
Scleroderma Therapy Solutions market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Scleroderma Therapy Solutions market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Immunotherapy
Anti-Fibrotic Drugs
Others

Segment by Application
Hospitals
Clinics
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bayer
Merck
AbbVie
Bristol-Myers Squibb
Sanofi
Roche
GlaxoSmithKline
Pfizer
Boehringer Ingelheim
Novartis

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Scleroderma Therapy Solutions Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Immunotherapy
1.2.3 Anti-Fibrotic Drugs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Scleroderma Therapy Solutions Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Scleroderma Therapy Solutions Market Perspective (2016-2027)
2.2 Scleroderma Therapy Solutions Growth Trends by Regions
2.2.1 Scleroderma Therapy Solutions Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Scleroderma Therapy Solutions Historic Market Share by Regions (2016-2021)
2.2.3 Scleroderma Therapy Solutions Forecasted Market Size by Regions (2022-2027)
2.3 Scleroderma Therapy Solutions Industry Dynamic
2.3.1 Scleroderma Therapy Solutions Market Trends
2.3.2 Scleroderma Therapy Solutions Market Drivers
2.3.3 Scleroderma Therapy Solutions Market Challenges
2.3.4 Scleroderma Therapy Solutions Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Scleroderma Therapy Solutions Players by Revenue
3.1.1 Global Top Scleroderma Therapy Solutions Players by Revenue (2016-2021)
3.1.2 Global Scleroderma Therapy Solutions Revenue Market Share by Players (2016-2021)
3.2 Global Scleroderma Therapy Solutions Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Scleroderma Therapy Solutions Revenue
3.4 Global Scleroderma Therapy Solutions Market Concentration Ratio
3.4.1 Global Scleroderma Therapy Solutions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Scleroderma Therapy Solutions Revenue in 2020
3.5 Scleroderma Therapy Solutions Key Players Head office and Area Served
3.6 Key Players Scleroderma Therapy Solutions Product Solution and Service
3.7 Date of Enter into Scleroderma Therapy Solutions Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Scleroderma Therapy Solutions Breakdown Data by Type
4.1 Global Scleroderma Therapy Solutions Historic Market Size by Type (2016-2021)
4.2 Global Scleroderma Therapy Solutions Forecasted Market Size by Type (2022-2027)

5 Scleroderma Therapy Solutions Breakdown Data by Application
5.1 Global Scleroderma Therapy Solutions Historic Market Size by Application (2016-2021)
5.2 Global Scleroderma Therapy Solutions Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Scleroderma Therapy Solutions Market Size (2016-2027)
6.2 North America Scleroderma Therapy Solutions Market Size by Type
6.2.1 North America Scleroderma Therapy Solutions Market Size by Type (2016-2021)
6.2.2 North America Scleroderma Therapy Solutions Market Size by Type (2022-2027)
6.2.3 North America Scleroderma Therapy Solutions Market Size by Type (2016-2027)
6.3 North America Scleroderma Therapy Solutions Market Size by Application
6.3.1 North America Scleroderma Therapy Solutions Market Size by Application (2016-2021)
6.3.2 North America Scleroderma Therapy Solutions Market Size by Application (2022-2027)
6.3.3 North America Scleroderma Therapy Solutions Market Size by Application (2016-2027)
6.4 North America Scleroderma Therapy Solutions Market Size by Country
6.4.1 North America Scleroderma Therapy Solutions Market Size by Country (2016-2021)
6.4.2 North America Scleroderma Therapy Solutions Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Scleroderma Therapy Solutions Market Size (2016-2027)
7.2 Europe Scleroderma Therapy Solutions Market Size by Type
7.2.1 Europe Scleroderma Therapy Solutions Market Size by Type (2016-2021)
7.2.2 Europe Scleroderma Therapy Solutions Market Size by Type (2022-2027)
7.2.3 Europe Scleroderma Therapy Solutions Market Size by Type (2016-2027)
7.3 Europe Scleroderma Therapy Solutions Market Size by Application
7.3.1 Europe Scleroderma Therapy Solutions Market Size by Application (2016-2021)
7.3.2 Europe Scleroderma Therapy Solutions Market Size by Application (2022-2027)
7.3.3 Europe Scleroderma Therapy Solutions Market Size by Application (2016-2027)
7.4 Europe Scleroderma Therapy Solutions Market Size by Country
7.4.1 Europe Scleroderma Therapy Solutions Market Size by Country (2016-2021)
7.4.2 Europe Scleroderma Therapy Solutions Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Scleroderma Therapy Solutions Market Size (2016-2027)
8.2 Asia-Pacific Scleroderma Therapy Solutions Market Size by Type
8.2.1 Asia-Pacific Scleroderma Therapy Solutions Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Scleroderma Therapy Solutions Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Scleroderma Therapy Solutions Market Size by Type (2016-2027)
8.3 Asia-Pacific Scleroderma Therapy Solutions Market Size by Application
8.3.1 Asia-Pacific Scleroderma Therapy Solutions Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Scleroderma Therapy Solutions Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Scleroderma Therapy Solutions Market Size by Application (2016-2027)
8.4 Asia-Pacific Scleroderma Therapy Solutions Market Size by Region
8.4.1 Asia-Pacific Scleroderma Therapy Solutions Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Scleroderma Therapy Solutions Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Scleroderma Therapy Solutions Market Size (2016-2027)
9.2 Latin America Scleroderma Therapy Solutions Market Size by Type
9.2.1 Latin America Scleroderma Therapy Solutions Market Size by Type (2016-2021)
9.2.2 Latin America Scleroderma Therapy Solutions Market Size by Type (2022-2027)
9.2.3 Latin America Scleroderma Therapy Solutions Market Size by Type (2016-2027)
9.3 Latin America Scleroderma Therapy Solutions Market Size by Application
9.3.1 Latin America Scleroderma Therapy Solutions Market Size by Application (2016-2021)
9.3.2 Latin America Scleroderma Therapy Solutions Market Size by Application (2022-2027)
9.3.3 Latin America Scleroderma Therapy Solutions Market Size by Application (2016-2027)
9.4 Latin America Scleroderma Therapy Solutions Market Size by Country
9.4.1 Latin America Scleroderma Therapy Solutions Market Size by Country (2016-2021)
9.4.2 Latin America Scleroderma Therapy Solutions Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Scleroderma Therapy Solutions Market Size (2016-2027)
10.2 Middle East & Africa Scleroderma Therapy Solutions Market Size by Type
10.2.1 Middle East & Africa Scleroderma Therapy Solutions Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Scleroderma Therapy Solutions Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Scleroderma Therapy Solutions Market Size by Type (2016-2027)
10.3 Middle East & Africa Scleroderma Therapy Solutions Market Size by Application
10.3.1 Middle East & Africa Scleroderma Therapy Solutions Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Scleroderma Therapy Solutions Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Scleroderma Therapy Solutions Market Size by Application (2016-2027)
10.4 Middle East & Africa Scleroderma Therapy Solutions Market Size by Country
10.4.1 Middle East & Africa Scleroderma Therapy Solutions Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Scleroderma Therapy Solutions Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Scleroderma Therapy Solutions Introduction
11.1.4 Bayer Revenue in Scleroderma Therapy Solutions Business (2016-2021)
11.1.5 Bayer Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Scleroderma Therapy Solutions Introduction
11.2.4 Merck Revenue in Scleroderma Therapy Solutions Business (2016-2021)
11.2.5 Merck Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Scleroderma Therapy Solutions Introduction
11.3.4 AbbVie Revenue in Scleroderma Therapy Solutions Business (2016-2021)
11.3.5 AbbVie Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Scleroderma Therapy Solutions Introduction
11.4.4 Bristol-Myers Squibb Revenue in Scleroderma Therapy Solutions Business (2016-2021)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Scleroderma Therapy Solutions Introduction
11.5.4 Sanofi Revenue in Scleroderma Therapy Solutions Business (2016-2021)
11.5.5 Sanofi Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Scleroderma Therapy Solutions Introduction
11.6.4 Roche Revenue in Scleroderma Therapy Solutions Business (2016-2021)
11.6.5 Roche Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Scleroderma Therapy Solutions Introduction
11.7.4 GlaxoSmithKline Revenue in Scleroderma Therapy Solutions Business (2016-2021)
11.7.5 GlaxoSmithKline Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Scleroderma Therapy Solutions Introduction
11.8.4 Pfizer Revenue in Scleroderma Therapy Solutions Business (2016-2021)
11.8.5 Pfizer Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Details
11.9.2 Boehringer Ingelheim Business Overview
11.9.3 Boehringer Ingelheim Scleroderma Therapy Solutions Introduction
11.9.4 Boehringer Ingelheim Revenue in Scleroderma Therapy Solutions Business (2016-2021)
11.9.5 Boehringer Ingelheim Recent Development
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Scleroderma Therapy Solutions Introduction
11.10.4 Novartis Revenue in Scleroderma Therapy Solutions Business (2016-2021)
11.10.5 Novartis Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Scleroderma Therapy Solutions Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immunotherapy
Table 3. Key Players of Anti-Fibrotic Drugs
Table 4. Key Players of Others
Table 5. Global Scleroderma Therapy Solutions Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Scleroderma Therapy Solutions Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Scleroderma Therapy Solutions Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Scleroderma Therapy Solutions Market Share by Regions (2016-2021)
Table 9. Global Scleroderma Therapy Solutions Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Scleroderma Therapy Solutions Market Share by Regions (2022-2027)
Table 11. Scleroderma Therapy Solutions Market Trends
Table 12. Scleroderma Therapy Solutions Market Drivers
Table 13. Scleroderma Therapy Solutions Market Challenges
Table 14. Scleroderma Therapy Solutions Market Restraints
Table 15. Global Scleroderma Therapy Solutions Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Scleroderma Therapy Solutions Market Share by Players (2016-2021)
Table 17. Global Top Scleroderma Therapy Solutions Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Scleroderma Therapy Solutions as of 2020)
Table 18. Ranking of Global Top Scleroderma Therapy Solutions Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Scleroderma Therapy Solutions Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Scleroderma Therapy Solutions Product Solution and Service
Table 22. Date of Enter into Scleroderma Therapy Solutions Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Scleroderma Therapy Solutions Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Scleroderma Therapy Solutions Revenue Market Share by Type (2016-2021)
Table 26. Global Scleroderma Therapy Solutions Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Scleroderma Therapy Solutions Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Scleroderma Therapy Solutions Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Scleroderma Therapy Solutions Revenue Market Share by Application (2016-2021)
Table 30. Global Scleroderma Therapy Solutions Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Scleroderma Therapy Solutions Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Scleroderma Therapy Solutions Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Scleroderma Therapy Solutions Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Scleroderma Therapy Solutions Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Scleroderma Therapy Solutions Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Scleroderma Therapy Solutions Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Scleroderma Therapy Solutions Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Scleroderma Therapy Solutions Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Scleroderma Therapy Solutions Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Scleroderma Therapy Solutions Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Scleroderma Therapy Solutions Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Scleroderma Therapy Solutions Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Scleroderma Therapy Solutions Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Scleroderma Therapy Solutions Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Scleroderma Therapy Solutions Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Scleroderma Therapy Solutions Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Scleroderma Therapy Solutions Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Scleroderma Therapy Solutions Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Scleroderma Therapy Solutions Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Scleroderma Therapy Solutions Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Scleroderma Therapy Solutions Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Scleroderma Therapy Solutions Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Scleroderma Therapy Solutions Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Scleroderma Therapy Solutions Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Scleroderma Therapy Solutions Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Scleroderma Therapy Solutions Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Scleroderma Therapy Solutions Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Scleroderma Therapy Solutions Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Scleroderma Therapy Solutions Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Scleroderma Therapy Solutions Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Scleroderma Therapy Solutions Market Size by Country (2022-2027) & (US$ Million)
Table 62. Bayer Company Details
Table 63. Bayer Business Overview
Table 64. Bayer Scleroderma Therapy Solutions Product
Table 65. Bayer Revenue in Scleroderma Therapy Solutions Business (2016-2021) & (US$ Million)
Table 66. Bayer Recent Development
Table 67. Merck Company Details
Table 68. Merck Business Overview
Table 69. Merck Scleroderma Therapy Solutions Product
Table 70. Merck Revenue in Scleroderma Therapy Solutions Business (2016-2021) & (US$ Million)
Table 71. Merck Recent Development
Table 72. AbbVie Company Details
Table 73. AbbVie Business Overview
Table 74. AbbVie Scleroderma Therapy Solutions Product
Table 75. AbbVie Revenue in Scleroderma Therapy Solutions Business (2016-2021) & (US$ Million)
Table 76. AbbVie Recent Development
Table 77. Bristol-Myers Squibb Company Details
Table 78. Bristol-Myers Squibb Business Overview
Table 79. Bristol-Myers Squibb Scleroderma Therapy Solutions Product
Table 80. Bristol-Myers Squibb Revenue in Scleroderma Therapy Solutions Business (2016-2021) & (US$ Million)
Table 81. Bristol-Myers Squibb Recent Development
Table 82. Sanofi Company Details
Table 83. Sanofi Business Overview
Table 84. Sanofi Scleroderma Therapy Solutions Product
Table 85. Sanofi Revenue in Scleroderma Therapy Solutions Business (2016-2021) & (US$ Million)
Table 86. Sanofi Recent Development
Table 87. Roche Company Details
Table 88. Roche Business Overview
Table 89. Roche Scleroderma Therapy Solutions Product
Table 90. Roche Revenue in Scleroderma Therapy Solutions Business (2016-2021) & (US$ Million)
Table 91. Roche Recent Development
Table 92. GlaxoSmithKline Company Details
Table 93. GlaxoSmithKline Business Overview
Table 94. GlaxoSmithKline Scleroderma Therapy Solutions Product
Table 95. GlaxoSmithKline Revenue in Scleroderma Therapy Solutions Business (2016-2021) & (US$ Million)
Table 96. GlaxoSmithKline Recent Development
Table 97. Pfizer Company Details
Table 98. Pfizer Business Overview
Table 99. Pfizer Revenue in Scleroderma Therapy Solutions Business (2016-2021) & (US$ Million)
Table 100. Pfizer Recent Development
Table 101. Boehringer Ingelheim Company Details
Table 102. Boehringer Ingelheim Business Overview
Table 103. Boehringer Ingelheim Scleroderma Therapy Solutions Product
Table 104. Boehringer Ingelheim Revenue in Scleroderma Therapy Solutions Business (2016-2021) & (US$ Million)
Table 105. Boehringer Ingelheim Recent Development
Table 106. Novartis Company Details
Table 107. Novartis Business Overview
Table 108. Novartis Scleroderma Therapy Solutions Product
Table 109. Novartis Revenue in Scleroderma Therapy Solutions Business (2016-2021) & (US$ Million)
Table 110. Novartis Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Scleroderma Therapy Solutions Market Share by Type: 2020 VS 2027
Figure 2. Immunotherapy Features
Figure 3. Anti-Fibrotic Drugs Features
Figure 4. Others Features
Figure 5. Global Scleroderma Therapy Solutions Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Scleroderma Therapy Solutions Report Years Considered
Figure 10. Global Scleroderma Therapy Solutions Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Scleroderma Therapy Solutions Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Scleroderma Therapy Solutions Market Share by Regions: 2020 VS 2027
Figure 13. Global Scleroderma Therapy Solutions Market Share by Regions (2022-2027)
Figure 14. Global Scleroderma Therapy Solutions Market Share by Players in 2020
Figure 15. Global Top Scleroderma Therapy Solutions Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Scleroderma Therapy Solutions as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Scleroderma Therapy Solutions Revenue in 2020
Figure 17. Global Scleroderma Therapy Solutions Revenue Market Share by Type (2016-2021)
Figure 18. Global Scleroderma Therapy Solutions Revenue Market Share by Type (2022-2027)
Figure 19. North America Scleroderma Therapy Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Scleroderma Therapy Solutions Market Share by Type (2016-2027)
Figure 21. North America Scleroderma Therapy Solutions Market Share by Application (2016-2027)
Figure 22. North America Scleroderma Therapy Solutions Market Share by Country (2016-2027)
Figure 23. United States Scleroderma Therapy Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Scleroderma Therapy Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Scleroderma Therapy Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Scleroderma Therapy Solutions Market Share by Type (2016-2027)
Figure 27. Europe Scleroderma Therapy Solutions Market Share by Application (2016-2027)
Figure 28. Europe Scleroderma Therapy Solutions Market Share by Country (2016-2027)
Figure 29. Germany Scleroderma Therapy Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Scleroderma Therapy Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Scleroderma Therapy Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Scleroderma Therapy Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Scleroderma Therapy Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Scleroderma Therapy Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Scleroderma Therapy Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Scleroderma Therapy Solutions Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Scleroderma Therapy Solutions Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Scleroderma Therapy Solutions Market Share by Region (2016-2027)
Figure 39. China Scleroderma Therapy Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Scleroderma Therapy Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Scleroderma Therapy Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Scleroderma Therapy Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Scleroderma Therapy Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Scleroderma Therapy Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Scleroderma Therapy Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Scleroderma Therapy Solutions Market Share by Type (2016-2027)
Figure 47. Latin America Scleroderma Therapy Solutions Market Share by Application (2016-2027)
Figure 48. Latin America Scleroderma Therapy Solutions Market Share by Country (2016-2027)
Figure 49. Mexico Scleroderma Therapy Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Scleroderma Therapy Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Scleroderma Therapy Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Scleroderma Therapy Solutions Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Scleroderma Therapy Solutions Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Scleroderma Therapy Solutions Market Share by Country (2016-2027)
Figure 55. Turkey Scleroderma Therapy Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Scleroderma Therapy Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Scleroderma Therapy Solutions Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Bayer Revenue Growth Rate in Scleroderma Therapy Solutions Business (2016-2021)
Figure 59. Merck Revenue Growth Rate in Scleroderma Therapy Solutions Business (2016-2021)
Figure 60. AbbVie Revenue Growth Rate in Scleroderma Therapy Solutions Business (2016-2021)
Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Scleroderma Therapy Solutions Business (2016-2021)
Figure 62. Sanofi Revenue Growth Rate in Scleroderma Therapy Solutions Business (2016-2021)
Figure 63. Roche Revenue Growth Rate in Scleroderma Therapy Solutions Business (2016-2021)
Figure 64. GlaxoSmithKline Revenue Growth Rate in Scleroderma Therapy Solutions Business (2016-2021)
Figure 65. Pfizer Revenue Growth Rate in Scleroderma Therapy Solutions Business (2016-2021)
Figure 66. Boehringer Ingelheim Revenue Growth Rate in Scleroderma Therapy Solutions Business (2016-2021)
Figure 67. Novartis Revenue Growth Rate in Scleroderma Therapy Solutions Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed


★調査レポート[世界の強皮症治療市場規模・現状・予測2021-2027] (コード:QY21JNE2850)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の強皮症治療市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆